Bio-Techne Corp. (TECH) Stock Price

TECHStock

$72.33+26.80%52W

Market Cap$11.27B

P/E154.07x

PEG Ratio0.97

Div yield0.50%

Beta1.31

TECH Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)10.77%

Price vs S&P 500 (4W)-2.61%

PEG Ratio0.97

VGM Score47.78

P/E Ratio (Annual)154.07x

Indicated Dividend Yield (Annual)0.50%

P/CF (Annual)39.33x

Book Value / Share (Quarterly)$13.32

P/TBV (Annual)5.19x

Indicated Dividend (Annual)$0.32

Revenue Growth (3Y)3.33%

Cash Flow / Share (Quarterly)$1.72

Payout Ratio (TTM)29.42%

Price vs S&P 500 (YTD)11.13%

Gross Margin (TTM)66.42%

Net Profit Margin (TTM)8.96%

EPS (TTM)$0.69

10-Day Avg Trading Volume2.71M

EPS Excl Extra (TTM)$0.69

Revenue Growth (5Y)10.55%

EPS (Annual)$0.46

Dividend / Share (Annual)$0.32

ROI (Annual)3.24%

Gross Margin (Annual)66.50%

Net Profit Margin (5Y Avg)17.06%

Cash / Share (Quarterly)$1.34

P/E Basic Excl Extra (TTM)104.27x

Revenue Growth QoQ (YoY)-1.51%

EPS Growth (5Y)-20.58%

P/E Normalized (Annual)154.07x

ROA (Last FY)2.87%

Revenue Growth TTM (YoY)0.17%

EBITD / Share (TTM)$1.62

ROE (5Y Avg)10.29%

Operating Margin (TTM)12.70%

Cash Flow / Share (Annual)$1.66

P/B Ratio5.42x

P/B Ratio (Quarterly)3.92x

Net Income / Employee (Annual)$23,700

EV / Revenue (TTM)9.33x

Net Interest Coverage (TTM)45.00x

ROA (TTM)4.27%

EPS Growth QoQ (YoY)128.22%

EV / EBITDA (TTM)44.47x

EPS Incl Extra (Annual)$0.46

Current Ratio (Annual)3.46x

Quick Ratio (Quarterly)3.18x

3-Month Avg Trading Volume4.29M

52-Week Price Return26.80%

EV / Free Cash Flow (Annual)44.04x

P/E Incl Extra (TTM)104.27x

Revenue / Employee (TTM)$390,600

Tangible BV / Share (Quarterly)$11.28

P/S Ratio (Annual)9.27x

Asset Turnover (Annual)0.48x

52-Week High$72.62

Operating Margin (5Y Avg)21.83%

EPS Excl Extra (Annual)$0.46

CapEx CAGR (5Y)-9.72%

Tangible BV CAGR (5Y)12.43%

26-Week Price Return22.01%

Quick Ratio (Annual)2.38x

13-Week Price Return52.82%

Total Debt / Equity (Annual)0.18x

Current Ratio (Quarterly)4.49x

Enterprise Value$11.30B

Revenue / Share Growth (5Y)10.25%

Asset Turnover (TTM)0.48x

Book Value / Share Growth (5Y)6.63%

Revenue / Employee (Annual)$393,400

Inventory Turnover (Annual)2.21x

Pretax Margin (Annual)8.07%

Cash / Share (Annual)$1.05

3-Month Return Std Dev47.50%

Gross Margin (5Y Avg)67.46%

Net Income / Employee (TTM)$35,000

EBITDA CAGR (5Y)-6.19%

EBITDA Interim CAGR (5Y)2.13%

ROE (Last FY)3.83%

Net Interest Coverage (Annual)27.65x

EPS Basic Excl Extra (Annual)$0.46

P/FCF (TTM)41.95x

Receivables Turnover (TTM)5.36x

EV / Free Cash Flow (TTM)41.91x

Total Debt / Equity (Quarterly)0.10x

EPS Incl Extra (TTM)$0.69

Receivables Turnover (Annual)5.44x

ROI (TTM)4.77%

Dividend Growth Rate (5Y)0.11%

P/S Ratio (TTM)9.34x

Pretax Margin (5Y Avg)19.41%

Revenue / Share (Annual)$7.64

Tangible BV / Share (Annual)$10.02

Forward P/E35.21x

Free OCF CAGR (5Y)10.82%

Price vs S&P 500 (52W)8.49%

P/E Ratio (TTM)104.27x

EPS Growth TTM (YoY)-15.90%

Year-to-Date Return23.09%

5-Day Price Return0.24%

EPS Normalized (Annual)$0.46

ROA (5Y Avg)7.59%

Net Profit Margin (Annual)6.02%

Month-to-Date Return0.42%

Cash Flow / Share (TTM)$2.20

EBITD / Share (Annual)$0.84

EPS Growth (3Y)-34.80%

Operating Margin (Annual)8.38%

LT Debt / Equity (Annual)0.18x

P/CF (TTM)38.35x

ROI (5Y Avg)8.77%

P/E Excl Extra (TTM)104.27x

LT Debt / Equity (Quarterly)0.10x

EPS Basic Excl Extra (TTM)$0.69

P/TBV (Quarterly)4.63x

Payout Ratio (Annual)68.65%

P/B Ratio (Annual)4.20x

Dividend / Share (TTM)$0.32

Inventory Turnover (TTM)2.07x

Pretax Margin (TTM)12.06%

Book Value / Share (Annual)$12.38

Price vs S&P 500 (13W)50.02%

Net Margin Growth (5Y)-27.97%

Dividend Yield (TTM)0.44%

Beta1.31x

P/FCF (Annual)44.08x

Revenue / Share (TTM)$7.69

ROE (TTM)5.44%

52-Week Low$43.20

vGradeD

gGradeC

mGradeB

vgmGradeC

TECH Earnings Surprise History

Q2 250.53est. 0.50

Q3 250.42est. 0.42

Q4 250.24est. 0.26

Q1 260.53est. 0.53

Q2 260.52est. 0.52

TECH Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.04

4.00

3.57

3.55

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
TECHBio-Techne Corp.	D	C	B	$72.33
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
RGENRepligen Corp	D	C	A	$181.69
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About Bio-Techne Corp.

Bio-Techne is a life sciences manufacturer providing consumables and instruments to pharmaceutical, biotech, academic, and diagnostic markets through two segments: protein sciences (75% of revenue), supplying reagents and analytical instruments including antibodies for protein analysis, and diagnostics and genomics (25%), offering diagnostic reagents, molecular diagnostics, and spatial biology products. The company generates approximately 55% of revenue from the United States, with the remainder from Europe, Asia-Pacific, and other international markets. This diversified product portfolio and geographic footprint position the company to serve multiple end-markets within the life sciences research and diagnostic sectors.